Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DHAI NASDAQ:GUTS NYSE:MLSS NASDAQ:ZYXI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDHAIDIH Holding US$0.24+4.6%$0.26$0.12▼$2.93$11.59M0.0913.63 million shs2.08 million shsGUTSFractyl Health$0.92+2.6%$1.38$0.83▼$3.50$46.41M1.55773,231 shs695,408 shsMLSSMilestone Scientific$0.62-0.5%$0.61$0.38▼$1.39$48.75M0.94204,310 shs49,788 shsZYXIZynex$1.49$1.97$1.23▼$9.42$45.14M1.02129,637 shs106,000 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDHAIDIH Holding US+4.62%-7.10%-3.70%+11.63%-89.45%GUTSFractyl Health+2.56%-4.98%-8.63%-53.63%-72.70%MLSSMilestone Scientific-0.55%+4.58%+14.28%-32.37%-36.95%ZYXIZynex0.00%-9.15%-3.87%-31.65%-80.77%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDHAIDIH Holding US$0.24+4.6%$0.26$0.12▼$2.93$11.59M0.0913.63 million shs2.08 million shsGUTSFractyl Health$0.92+2.6%$1.38$0.83▼$3.50$46.41M1.55773,231 shs695,408 shsMLSSMilestone Scientific$0.62-0.5%$0.61$0.38▼$1.39$48.75M0.94204,310 shs49,788 shsZYXIZynex$1.49$1.97$1.23▼$9.42$45.14M1.02129,637 shs106,000 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDHAIDIH Holding US+4.62%-7.10%-3.70%+11.63%-89.45%GUTSFractyl Health+2.56%-4.98%-8.63%-53.63%-72.70%MLSSMilestone Scientific-0.55%+4.58%+14.28%-32.37%-36.95%ZYXIZynex0.00%-9.15%-3.87%-31.65%-80.77%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDHAIDIH Holding US 0.00N/AN/AN/AGUTSFractyl Health 3.00Buy$6.53607.99% UpsideMLSSMilestone Scientific 3.00Buy$1.25102.56% UpsideZYXIZynex 2.33Hold$4.90228.86% UpsideCurrent Analyst Ratings BreakdownLatest DHAI, ZYXI, GUTS, and MLSS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/28/2025GUTSFractyl HealthLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$3.608/14/2025GUTSFractyl HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$12.00 ➝ $6.008/1/2025ZYXIZynexLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Buy$3.708/1/2025ZYXIZynexHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Neutral7/15/2025ZYXIZynexRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetSector Perform$4.00 ➝ $3.006/30/2025ZYXIZynexHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$8.00(Data available from 9/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDHAIDIH Holding US$64.47M0.18N/AN/A($0.80) per share-0.31GUTSFractyl Health$90K515.64N/AN/A$0.59 per share1.56MLSSMilestone Scientific$9.08M5.34N/AN/A$0.11 per share5.61ZYXIZynex$192.35M0.23$0.24 per share6.10$1.12 per share1.33Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDHAIDIH Holding US-$8.44M-$0.30N/A∞N/A-13.59%N/A-25.97%N/AGUTSFractyl Health-$68.69M-$2.06N/AN/AN/A-73,864.52%-584.35%-102.88%11/11/2025 (Estimated)MLSSMilestone Scientific-$6.93M-$0.09N/A∞N/A-52.01%-60.26%-40.23%N/AZYXIZynex$2.99M-$0.94N/A3.17N/A-19.79%-78.54%-16.70%10/30/2025 (Estimated)Latest DHAI, ZYXI, GUTS, and MLSS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025GUTSFractyl Health-$0.37-$0.53-$0.16-$0.57N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDHAIDIH Holding USN/AN/AN/AN/AN/AGUTSFractyl HealthN/AN/AN/AN/AN/AMLSSMilestone ScientificN/AN/AN/AN/AN/AZYXIZynexN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDHAIDIH Holding USN/A0.510.34GUTSFractyl Health4.611.221.22MLSSMilestone ScientificN/A2.851.86ZYXIZynex0.560.620.45Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDHAIDIH Holding US27.76%GUTSFractyl HealthN/AMLSSMilestone Scientific5.79%ZYXIZynex29.68%Insider OwnershipCompanyInsider OwnershipDHAIDIH Holding US27.00%GUTSFractyl Health26.10%MLSSMilestone Scientific24.75%ZYXIZynex49.28%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDHAIDIH Holding USN/A47.34 million34.56 millionN/AGUTSFractyl Health10250.29 million37.16 millionN/AMLSSMilestone Scientific3078.56 million58.61 millionOptionableZYXIZynex77030.30 million15.37 millionOptionableDHAI, ZYXI, GUTS, and MLSS HeadlinesRecent News About These CompaniesZynex announces new executive teamAugust 18, 2025 | msn.comZynex welcomes Steve Dyson as CEO, adds to leadership teamAugust 18, 2025 | proactiveinvestors.comZynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key RolesAugust 18, 2025 | prnewswire.comZynex, Inc. Investors: Company Investigated by the Portnoy Law FirmAugust 14, 2025 | globenewswire.comZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmAugust 13, 2025 | globenewswire.comZynex Q2 Revenue Drops 55%August 5, 2025 | fool.comZynex Inc. Faces Challenges Amid Strategic ShiftsAugust 4, 2025 | theglobeandmail.comZynex, Inc. (NASDAQ:ZYXI) Q2 2025 Earnings Call TranscriptAugust 1, 2025 | msn.comHC Wainwright & Co. Downgrades Zynex (ZYXI)August 1, 2025 | msn.comZynex, Inc.: Zynex Reports Second Quarter 2025 Financial ResultsAugust 1, 2025 | finanznachrichten.deZynex Inc (ZYXI) Q2 2025 Earnings Report Preview: What to Look ForAugust 1, 2025 | finance.yahoo.comZynex, Inc. (ZYXI) Q2 2025 Earnings Call TranscriptJuly 31, 2025 | seekingalpha.comZynex Inc. (ZYXI) Reports Q2 Loss, Misses Revenue EstimatesJuly 31, 2025 | zacks.comZynex eyes growth revival under new CEO, advances oximeter technologyJuly 31, 2025 | proactiveinvestors.comZynex Reports Second Quarter 2025 Financial ResultsJuly 31, 2025 | prnewswire.comZynex Sets Second Quarter 2025 Earnings CallJuly 22, 2025 | prnewswire.comZynex: New CEO Steven Dyson shares his vision – ICYMIJuly 12, 2025 | proactiveinvestors.comZynex: New CEO Steven Dyson shares his vision – ICYMIJuly 12, 2025 | proactiveinvestors.comZynex Shareholder Sues Board, Execs Over Insurer’s Payment PauseJuly 11, 2025 | news.bloomberglaw.comNZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmJuly 10, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDHAI, ZYXI, GUTS, and MLSS Company DescriptionsDIH Holding US NASDAQ:DHAI$0.24 +0.01 (+4.62%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$0.24 -0.01 (-3.59%) As of 09/5/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.Fractyl Health NASDAQ:GUTS$0.92 +0.02 (+2.56%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$0.92 +0.00 (+0.24%) As of 09/5/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.Milestone Scientific NYSE:MLSS$0.62 0.00 (-0.55%) Closing price 09/5/2025 03:59 PM EasternExtended Trading$0.61 -0.01 (-1.15%) As of 09/5/2025 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.Zynex NASDAQ:ZYXI$1.49 0.00 (0.00%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$1.49 0.00 (0.00%) As of 09/5/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/01 - 09/05 Lululemon Share Price Has Plenty of Room Left to Fall Why DocuSign Could Be a SaaS Value Play After Q2 Earnings Why Hedge Fund Elliott Bet $4B on Pepsi and Sees Over 50% Upside Palantir Insider Selling: Risk Signal or Normal Activity? Advanced Micro Devices' 2026 Forecasts Are Way Too Low Salesforce Stumbles, But Investors Eye a Major Comeback Buy the Dip? GitLab’s Bullish Case Outweighs the Bears Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
